Five Prime Therapeutics

YTD

ALL

Why Robinhood?

You can watch FPRX and buy or sell other stocks, ETFs, and their options commission-free!

About FPRX

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150.

CEO

David M. Reese, MD

CEODavid M. Reese, MD

Employees

—

Employees—

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2001

Founded2001

Employees

—

Employees—

FPRX Key Statistics

Market cap

1.77B

Market cap1.77B

Price-Earnings ratio

-14.16

Price-Earnings ratio-14.16

Dividend yield

—

Dividend yield—

Average volume

1.11M

Average volume1.11M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$38.90

52 Week high$38.90

52 Week low

$2.64

52 Week low$2.64

People also own

Based on the portfolios of people who own FPRX. This list is generated using Robinhood data, and it’s not a recommendation.